๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of oral leukoplakia with topical bleomycin. A pilot study

โœ Scribed by F. Wong; J. Epstein; A. Millner


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
538 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Topical bleomycin for the treatment of d
โœ Joel B. Epstein; Meir Gorsky; Frances L. W. Wong; Amelia Millner ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 2 views

## BACKGROUND. Because malignant transformation of dysplastic oral leukoplakia has been reported in up to 43% of cases, these lesions must be managed. ## METHODS. This study evaluated the use of topical 1% bleomycin in dimethylsulfoxide for the treatment of dysplastic oral lesions. Bleomycin wa

Topical bleomycin treatment of oral leuk
โœ Joel B. Epstein; Frances L. W. Wong; Amelia Millner; Nhu D. Le ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 570 KB

## Abstract __Background.__ Oral leukoplakia and oral erythroplakia may be associated with benign and dysplastic cellular changes, and are at risk of malignant transformation. Additional means of management of these lesions is needed. The results of nonblinded trials using topical bleomycin in oral

Successful treatment of oral verrucous h
โœ Hsin-Ming Chen; Chuan-Hang Yu; Ping-Chin Tu; Chien-Yang Yeh; Tsuimin Tsai; Chun- ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Background and objectives: Our recent studies showed that a new topical 5-aminolevulinic acid-mediated photodynamic therapy (ala-pdt) protocol using a light-emitting diode (led) light source is an effective and successful treatment modality for five cases of oral verrucous hyperplasia (ovh) and

Topical treatment of psoriasis with the
โœ V. A. Bohr; E. A. Abel; E. M. Farber; P. C. Hanawalt ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 666 KB

Our studies in human epidermal keratinocytes as a model system have suggested that the antibiotic topoisomerase II inhibitors, novobiocin and nalidixic acid, may be of value for the treatment of hyperproliferative skin disorders. We have therefore conducted a pilot study of the clinical efficacy of